Markets
Security | Price ▲ | % | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
Port Erin Biopharma Investments Ltd |
€0.060
10.09.24 |
-1.640% | 0 | 0 | - | - |
Melinta Therapeutics Inc. |
€0.060
21.04.20 |
- | 0 | 0 | - | - |
Bellicum Pharmaceuticals Inc. |
€0.064
05.03.24 |
-9.290% | 0 | 10 | - | - |
PhaseBio Pharmaceuticals Inc |
€0.068
24.02.23 |
- | 0 | 0 | - | - |
Pt Tempo Scan Rp 50 |
€0.069
26.02.21 |
-0.720% | 0 | 0 | - | - |
Heat Biologics Inc. |
€0.069
14.06.24 |
-24.860% | 0 | 0 | - | - |
Mologen AG |
€0.071
27.11.20 |
-13.790% | 0 | 0 | - | - |
Nordic Nanovector ASA |
€0.074
10.09.24 |
-0.540% | 0 | 0 | - | - |
LexaGene Holdings Inc. |
€0.075
21.07.23 |
- | 0 | 0 | - | - |
PharmAust Ltd. |
€0.076
10.09.24 |
4.140% | 0 | 0 | - | - |
Clovis Oncology Inc. |
€0.077
03.04.23 |
- | 0 | 0 | - | - |
Onxeo S.A. |
€0.078
10.09.24 |
13.720% | 0 | 0 | - | - |
Super League Gaming Inc |
€0.080
20.11.23 |
-6.540% | 0 | 0 | - | - |
Cannabics Pharmaceuticals Inc |
€0.081
20.08.22 |
- | 0 | 0 | - | - |
Invitae Corp |
€0.083
16.02.24 |
-78.840% | 0 | 0 | - | - |
Otonomy Inc. |
€0.083
14.04.23 |
- | 0 | 0 | - | - |
Matinas BioPharma Holdings Inc |
€0.084
27.08.24 |
0.550% | 0 | 0 | - | - |
Arovella Therapeutics Ltd. |
€0.084
10.09.24 |
3.700% | 0 | 0 | - | - |
VBI Vaccines Inc. |
€0.085
07.08.24 |
113.920% | 0 | 0 | - | - |
MYM Nutraceuticals Inc. |
€0.088
05.11.21 |
- | 0 | 0 | - | - |
Phylogica Ltd. |
€0.089
18.08.21 |
- | 0 | 0 | - | - |
E-Therapeutics Plc |
€0.091
08.05.24 |
-7.610% | 0 | 0 | - | - |
Kalbe Farma |
€0.093
10.09.24 |
0.540% | 0 | 0 | - | - |
Athersys Inc. |
€0.095
20.11.23 |
6.990% | 0 | 0 | - | - |
Seelos Therapeutics Inc. |
€0.097
27.11.23 |
-19.490% | 0 | 0 | - | - |
Aradigm Corp. New |
€0.097
18.07.19 |
-12.150% | 0 | 0 | - | - |
Wildflower Marijuana |
€0.098
30.04.22 |
- | 0 | 0 | - | - |
Antibe Therapeutics Inc. |
€0.10
16.04.24 |
31.580% | 0 | 0 | - | - |
Nuvectra Corp |
€0.10
13.12.19 |
-23.080% | 0 | 0 | - | - |
Maven Brands Inc. |
€0.10
23.02.22 |
-18.160% | 0 | 0 | - | - |